Stanimira Krotneva Selected Research

Multiple Myeloma

1/2021

Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stanimira Krotneva Research Topics

Disease

3	Systolic Heart Failure 01/2017 - 01/2016
2	Heart Failure 01/2017 - 01/2016
1	Hepatocellular Carcinoma (Hepatoma) 06/2023
1	Diarrhea 06/2023
1	Fatigue 06/2023
1	Multiple Myeloma 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019
1	Drug-Related Side Effects and Adverse Reactions 11/2013
1	Ataxia (Dyssynergia) 11/2013
1	Breast Neoplasms (Breast Cancer) 07/2013

Drug/Important Bio-Agent (IBA)

3	IvabradineIBA 01/2017 - 01/2016
1	regorafenibIBA 06/2023
1	cabozantinibIBA 06/2023
1	Tyrosine Kinase InhibitorsIBA 06/2023
1	Thalidomide (Thalomid)FDA Link 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	daratumumabIBA 01/2021
1	Bortezomib (Velcade)FDA Link 01/2021
1	brigatinibIBA 01/2019
1	alectinibIBA 01/2019
1	ceritinibIBA 01/2019
1	CrizotinibIBA 01/2019
1	Anaplastic Lymphoma KinaseIBA 01/2019

Therapy/Procedure

1	Drug Tapering 06/2023
1	Patient Readmission 01/2017
1	Therapeutics 01/2016
1	Medication Reconciliation 11/2013
1	Adjuvant Radiotherapy 07/2013
1	Radiotherapy 07/2013
1	Segmental Mastectomy (Lumpectomy) 07/2013